Aldara for the Treatment of Large and/or Multiple sBCC

NCT00189280 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Basal Cell

Interventions

DRUG: Imiquimod

Sponsor

MEDA Pharma GmbH & Co. KG